Literature DB >> 8942696

Grand rounds--Nottingham City Hospital. A rare cause of superior vena cava obstruction.

T W Harrison1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8942696      PMCID： PMC2352759          DOI： 10.1136/bmj.313.7068.1324

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  A clinicopathologic analysis of adriamycin cardiotoxicity.

Authors:  E A Lefrak; J Pitha; S Rosenheim; J A Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

2.  Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation.

Authors:  M E Billingham; M R Bristow; E Glatstein; J W Mason; M A Masek; J R Daniels
Journal:  Am J Surg Pathol       Date:  1977-03       Impact factor: 6.394

Review 3.  Primary lymphoma of the pericardium: report on a "cured" case and review of the literature.

Authors:  N A Pavlidis; M Elisaf; M Bai; C Tolis; C Papadimitriou
Journal:  Med Pediatr Oncol       Date:  1994

4.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

5.  Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.

Authors:  M R Bristow; J W Mason; M E Billingham; J R Daniels
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

6.  Intracardiac malignant lymphoma detected by gallium-67 citrate and thallium-201 chloride.

Authors:  S Hamada; T Nishimura; K Hayashida; T Uehara
Journal:  J Nucl Med       Date:  1988-11       Impact factor: 10.057

Review 7.  Causes and management of superior vena cava syndrome.

Authors:  C P Escalante
Journal:  Oncology (Williston Park)       Date:  1993-06       Impact factor: 2.990

Review 8.  Extensive surgery for primary malignant lymphoma of the heart.

Authors:  M Takagi; T Kugimiya; T Fujii; H Yamauchi; R Shibata; M Narimatsu; N Tsuda
Journal:  J Cardiovasc Surg (Torino)       Date:  1992 Sep-Oct       Impact factor: 1.888
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.